Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

Others

Items 1-10 of 316

Page
per page
  1. Doxycycline hyclate
    A4052 Doxycycline hyclate
    Target: MMP
    Summary: MMP inhibitor
      ≥22.15 mg/mL
  2. Cyclophosphamide monohydrate
    A4232 Cyclophosphamide monohydrate
    Summary: alkylating, cytotoxic agent,antitumor activity
      ≥13.95 mg/mL
  3. 7-Methoxycoumarin-4-acetyl-P-L-G-L-β-(2,4-dinitrophenylamino)A-R amide
    A1500 7-Methoxycoumarin-4-acetyl-P-L-G-L-β-(2,4-dinitrophenylamino)A-R amide
    Summary: Substrate of matrix metalloproteinases assay
      ≥48.7 mg/mL
      insoluble in H2O
  4. Mca-Pro-Leu-NH2
    A1501 Mca-Pro-Leu-NH2
    Summary: Substrate of matrix metalloproteinases assay
  5. Ansamitocin P-3
    A3183 Ansamitocin P-3
    Target: Microtubules/Tubulins
    Summary: Inhibitor of tublin spiralization,maytansine analog
      ≥31.75 mg/mL
  6. Benfotiamine
    A3236 Benfotiamine
    Summary: Drug for painful nerve condition
      insoluble in H2O; insoluble in EtOH; insoluble in DMSO
  7. Elacridar
    A3384 Elacridar
    Target: P-glycoprotein (P-gp)
    Summary: BCRP inhibitor
      ≥56.4 mg/mL
  8. Elacridar hydrochloride
    A3385 Elacridar hydrochloride
    Summary: BCRP and P-GP inhibitor
      Soluble in DMSO
  9. Etofenamate
    A3403 Etofenamate
    Summary: Non-steroidal anti-inflammatory drug
  10. Kaempferide
    A3522 Kaempferide
    Summary: O-methylated flavonol
      insoluble in H2O; insoluble in EtOH; ≥16.53 mg/mL

Items 1-10 of 316

Page
per page
Relate Categories
Specificity
  1. Selective42item
  2. Non-Selective1 item
Reversibility
  1. Irreversible1 item
Target
  1. MMP1 item
  2. Voltage-gated Potassium (KV) Channels1 item
  3. Farnesoid X receptors (FXRs)1 item
  4. P-glycoprotein (P-gp)1 item
  5. Neuraminidases (NA)1 item
  6. RARs1 item
  7. Microtubules/Tubulins1 item
  8. AMPK1 item
  9. eIF4E/eIF3G interaction1 item
  10. Topoisomerases1 item
  11. Cytochrome P450 (CYP450)1 item
  12. Toll-like receptors (TLRs)1 item
  13. BMI-11 item
  14. MLK31 item
  15. Protease-Activated Receptors1 item
  16. Calcium chelator1 item
  17. Dehydrogenase1 item
  18. BCPCF efflux1 item
  19. D1 and D5 Receptors1 item
  20. D2 Receptors1 item
  21. D3 Receptors1 item
  22. Angiotensin-Converting Enzymes (ACEs)1 item
  23. Autophagy1 item
  24. COX1 item
  25. C5a receptors1 item
  26. YAP1 item
  27. eIF4F1 item
  28. Glutaminases2item
  29. Carbonic Anhydrases3item
  30. BLM1 item
  31. NADPH Oxidases1 item
  32. TAK11 item
  33. Histamine H1 Receptors1 item
  34. DYRK1 item
  35. Ionophores1 item
  36. MNK1 item
  37. eEF-21 item
  38. Inward Rectifier Potassium (Kir) Channels1 item
  39. fibrinolysis1 item
  40. D4 Receptors1 item
  41. Aldosterone receptor1 item
  42. Hydroxylases1 item
  43. Antioxidants1 item
  44. ATGL1 item
  45. AChR1 item
  46. calcium uptake1 item
  47. haspin kinase1 item
  48. STK1 item
  49. GABA receptors1 item
  50. Vitamin D receptors (VDRs)1 item
  51. Pregnane X receptor(PXR)1 item
  52. ICAM1 item
  53. sodium chloride cotransporter1 item
  54. DprE1 item
  55. Histone Methyltransferase1 item
Reported Experiments
  1. Animal Experiments55item
  2. Cell Experiments51item
Related Disease
  1. Acute Myeloid Leukemia2item
  2. Bladder Cancer1 item
  3. Brain Injuries Studies1 item
  4. Breast Cancer4item
  5. Cancer17item
  6. Colon Cancer2item
  7. Colorectal Cancer2item
  8. Dyslipidemia1 item
  9. Glioblastoma1 item
  10. Glioma1 item
  11. HIV2item
  12. Inflammatory Diseases4item
  13. Lung Cancer3item
  14. Lymphoma2item
  15. Osteoporosis1 item
  16. Pancreatic Cancer1 item
  17. Schizophrenia1 item
  18. Tuberculosis1 item